4.7 Article

Thermoresponsive supramolecular micellar drug delivery system based on star-linear pseudo-block polymer consisting of β-cyclodextrin-poly(N-isopropylacrylamide) and adamantyl-poly(ethylene glycol)

Journal

JOURNAL OF COLLOID AND INTERFACE SCIENCE
Volume 490, Issue -, Pages 372-379

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.jcis.2016.11.056

Keywords

beta-Cyclodextrin; Poly(N-isopropylacrylamide); Poly(ethylene glycol); Doxorubicin; Drug delivery

Funding

  1. Ministry of Education - Singapore [R-397-000-188-112, R-397-000-136-112]
  2. National University of Singapore [R-397-000- 136-731]

Ask authors/readers for more resources

Chemotherapy is facing several limitations such as low water solubility of anticancer drugs and multidrug resistance (MDR) in cancer cells. To overcome these limitations, a thermoresponsive micellar drug delivery system formed by a non-covalently connected supramolecular block polymer was developed. The system is based on the host-guest interaction between a well-defined beta-cyclodextrin (beta-CD) based poly(N-isopropylacrylamide) star host polymer and an adamantyl-containing poly(ethylene glycol) (Ad-PEG) guest polymer. The structures of the host and guest polymers were characterized by H-1 and C-13 NMR, GPC and FTIR. Subsequently, they formed a pseudo-block copolymer via inclusion complexation between beta-CD core and adamantyl-moiety, which was confirmed by 2D NMR. The thermoresponsive micellization of the copolymer was investigated by UV-vis spectroscopy, DLS and TEM. At 37 degrees C, the copolymer at a concentration of 0.2 mg/mL in PBS formed micelles with a hydrodynamic diameter of ca. 282 nm. The anticancer drug, doxorubicin (DOX), was successfully loaded into the core of the micelles with a loading level of 6% and loading efficiency of 17%. The blank polymer micelles showed good biocompatibility in cell cytotoxicity studies. Moreover, the DOX-loaded micelles demonstrated superior therapeutic effects in AT3B-1-N (MDR-) and AT3B-1 (MDR+) cell lines as compared to free DOX control, overcoming MDR in cancer cells. (C) 2016 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available